An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on an online forum asked a practical question: if they were using three peptides together — CJC-1295, ipamorelin, and BPC-157 — how often should they inject them and how should they cycle the trio. The post is a user asking for dosing and scheduling advice, not a clinical guideline or study result. Quickly, what those three substances are: CJC-1295 and ipamorelin are both synthetic peptides that act like signals to the body’s pituitary gland to release more growth hormone (that’s a hormone involved in growth, repair, and metabolism). CJC-1295 is a longer‑acting “growth hormone releasing” peptide, and ipamorelin is a shorter acting one that also prompts growth hormone release. BPC-157 is a different peptide derived from a protein in the stomach; people say it helps tissue healing and inflammation. None of these are standard prescription medicines for general anti‑aging or performance use; some are researched in animals, some have limited human data, and many uses discussed online are off‑label or experimental. What we actually know from the scientific record is mixed and mostly limited. Much of the concrete data comes from animal studies or very small human studies. CJC-1295 can raise blood levels of growth hormone and a related marker called IGF-1 for periods of time. Ipamorelin stimulates short bursts of growth hormone release and is often paired with longer‑acting peptides to get both spikes and sustained effects. BPC-157 shows tissue‑healing effects in many animal experiments (tendons, gut lining, wound healing), but reliable, large human trials are largely lacking. The forum question is asking for a regimen, which is advice based on anecdote and underground practices rather than validated clinical trials. That means reported schedules vary widely and outcomes, safety, and side effects aren’t well documented in rigorous studies. Why people care: those looking for faster recovery from injuries, better muscle or fat outcomes, or anti‑aging effects are often the audience. The idea of combining a growth hormone secretagogue (the two GH‑releasing peptides) with a tissue‑repair peptide (BPC-157) seems logical to users who want both anabolic (build/repair) and healing effects. If any of the peptides did what people hope, they might speed recovery or alter body composition. But because evidence is limited, the practical takeaway is that you can find many suggested schedules online, but they’re not validated and could be inconsistent in effect. Important caveats and risks: these peptides are largely unregulated for human use in many places. Purity and dosing from gray‑market vendors can be unreliable. Increasing growth hormone can carry risks: fluid retention, joint pain, insulin resistance (affecting blood sugar), and possibly effects on tumor growth if cancer is present. BPC-157’s safety in humans over time isn’t well established. People with medical conditions, pregnant or breastfeeding people, and those on other medications should be particularly cautious. Because forum posts are personal reports, they can’t replace medical advice. If someone is seriously considering this, they should consult a doctor who understands endocrine effects and ideally get monitored blood tests rather than following internet protocols. Bottom line: the forum question asks how to dose and cycle a combo that’s mainly supported by anecdote and limited studies; there’s no universally safe, proven schedule to recommend, and anyone considering this should get medical guidance and be aware of uncertain benefits and real risks.
Source: r/Peptides